Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

Re: "Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy"

(2013) D. M. Skowronski et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

(2013) Janet E McElhaney et al.   LANCET INFECTIOUS DISEASES

Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy

(2012) S. Mannino et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

(2012) Laurent Coudeville et al.   BMC Medical Research Methodology

Influenza vaccination coverage across ethnic groups in Canada

(2012) S. Quach et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Association between obesity and vulnerability and serologic response to influenza vaccination in older adults

(2012) H.K. Talbot et al.   VACCINE

The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

(2012) Janet E. McElhaney et al.   VACCINE

Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada

(2011) David N. Fisman et al.   PLoS One

Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults

(2011) Xu Yao et al.   VACCINE

Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study

(2010) Pierre Van Damme et al.   BMC INFECTIOUS DISEASES

Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy Older Adults

(2010) Ru‐Chien Chi et al.   CLINICAL INFECTIOUS DISEASES

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

(2010) Camille Reygrobellet et al.   Human vaccines & immunotherapeutics

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

(2009) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study

(2009) Robert Arnou et al.   VACCINE

A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials

(2009) Thierry Boge et al.   VACCINE

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

(2009) Michele Pellegrini et al.   VACCINE

MF59® -adjuvanted vaccines for seasonal and pandemic influenza prophylaxis

(2008) Angelika Banzhoff et al.   Influenza and Other Respiratory Viruses

Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

(2008) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

(2008) David Holland et al.   JOURNAL OF INFECTIOUS DISEASES

Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

(2008) Sanae Sasaki et al.   PLoS One

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial

(2008) N. Groth et al.   VACCINE

In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses

(2008) Mary Dawn T. Co et al.   VACCINE